Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gliadel wafers for supratentorial brain metastases
NCT00003878Phase 2Completed
- Sponsor
- New Approaches to Brain Tumor Therapy Consortium
- Start
- Apr 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carmustine in brain metastases, sponsored by New Approaches to Brain Tumor Therapy Consortium. Started Apr 2002; status: completed.
02
Drugs
carmustine
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT00003878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003878.